Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Neutralizing Antibody Market?

In recent times, the market size for neutralizing antibodies has experienced a significant expansion. It is expected to develop from a value of $230.25 billion in 2024 up to $257.81 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. This surge during the historic period can be traced back to factors such as an increase in the approval of biologics, a growing investment in antibody research, an escalating prevalence of perennial viral infections, a higher consciousness about immunotherapy, and a rise in healthcare expenditure.

What Growth Rate Is Forecasted for the Neutralizing Antibody Market by 2029?

The market size of neutralizing antibodies is poised to experience a swift surge in the coming years, with projections suggesting it will reach $401.16 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.7%. The escalation during this forecast period can be traced back to the augmenting incidence of novel infectious diseases, elevation in autoimmune disorders, the evolving pipeline for antibody-based therapeutic measures, the mounting requirement for precision medicine, and a spike in the demand for targeted therapies. The forecast period also witnesses some major trends such as a tilt towards bispecific and multispecific antibodies, the application of artificial intelligence (AI) in the discovery of antibodies, progression in antibody-drug conjugates, the expanding usage of plant-production of antibodies, and an increase in customized immunotherapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24620&type=smp

Which Key Companies Are Shaping the Future of the Neutralizing Antibody Market?

Major companies operating in the neutralizing antibody market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AstraZeneca PLC, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., GeNext Genomics, Celltrion Healthcare Co. Ltd, BeiGene Ltd, AbCellera Biologics Inc., BMC Pharmacology and Toxicology, Anthos Therapeutics, Immunome Inc., Sorrento Therapeutics Inc., Tonix Pharmaceuticals, Abwiz Bio, AXIM Biotechnologies.

Which Factors Are Driving Demand in the Neutralizing Antibody Industry?

The growth of the neutralizing antibody market is projected to be driven by the increasing occurrence of infectious diseases. These diseases, which are caused by harmful organisms like bacteria, viruses, fungi, or parasites, can be transmitted either directly or indirectly from one individual to another. The surge in infectious diseases can be attributed to increased travel, which allows disease-causing pathogens to swiftly penetrate borders. Neutralizing antibodies contribute to the treatment of infectious diseases by accurately identifying and neutralizing pathogens, thus acting as an effective barrier against disease progression. They enhance patient prognosis by delivering accurate and prompt immune response. For example, the UK Health Security Agency, a UK government institution, reported in February 2024 that tuberculosis cases (a transmittable bacterial infection mainly impacting the lungs) in England increased by 10.7% from 4,380 in 2022 to 4,850 in 2023. Consequently, the escalating occurrence of infectious diseases is fostering the growth of the neutralizing antibody market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24620&type=smp

How Is the Neutralizing Antibody Market Segmented by Several Divisions?

The neutralizing antibody market covered in this report is segmented –

1) By Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies

2) By Target Virus: SARS-CoV-2 (COVID-19), Human Immunodeficiency Viruses (HIV), Influenza, Ebola, Zika, Hepatitis C, Other Target Viruses

3) By Distribution Channel: Direct Sales To End-Users, Distributors, Online Retail, Other Distribution Channels

4) By Application: Therapeutics, Diagnostics, Research And Development

5) By End User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Monoclonal Antibodies: Fully Human Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Murine Monoclonal Antibodies

2) By Polyclonal Antibodies: Animal-Derived Polyclonal Antibodies, Recombinant Polyclonal Antibodies, Human Polyclonal Antibody Preparations

What are the Emerging Market Trends Driving the Growth of the Neutralizing Antibody Industry?

Key players in the neutralizing antibody market are concentrating their efforts on creating cutting-edge therapeutic methods like targeted therapies, with the aim to effectively neutralize viruses and inhibit their invasion into human cells, therefore battling infectious diseases. Targeted therapies are treatments that aim specifically at molecular markers or pathways that contribute to the expansion and survival of disease-inducing cells, like cancer cells or viruses. For example, Eli Lilly and Company, an American pharmaceutical firm, was granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for Bebtelovimab, a neutralizing monoclonal antibody therapy specifically for COVID-19, in February 2022. Bebtelovimab is formulated to address mild to moderate COVID-19 in patients who are susceptible to advancing to severe illness, encompassing hospitalization or death. This approval facilitates expedient treatment in the face of rising viral variants, thereby promoting strategies to lessen disease severity and enhance patient prognosis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neutralizing-antibody-global-market-report

Which Regions Are Driving Growth in the Neutralizing Antibody Market?

North America was the largest region in the neutralizing antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neutralizing antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24620

This Report Delivers Insight On:

1. How big is the neutralizing antibody market, and how is it changing globally?

2. Who are the major companies in the neutralizing antibody market, and how are they performing?

3. What are the key opportunities and risks in the neutralizing antibody market right now?

4. Which products or customer segments are growing the most in the neutralizing antibody market?

5. What factors are helping or slowing down the growth of the neutralizing antibody market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model